<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Regulatory Risk on FinanClub</title>
    <link>https://finan.club/tags/regulatory-risk/</link>
    <description>Recent content in Regulatory Risk on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 10 Apr 2024 09:02:18 +0000</lastBuildDate><atom:link href="https://finan.club/tags/regulatory-risk/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>DOC</title>
      <link>https://finan.club/us/doc/</link>
      <pubDate>Wed, 10 Apr 2024 09:02:18 +0000</pubDate>
      
      <guid>https://finan.club/us/doc/</guid>
      <description>score:89
Chances: Healthpeak Properties, Inc. is a leading owner, operator, and developer of real estate for healthcare discovery and delivery, positioning it well to capitalize on the secular trends of the industry. The company operates through segments such as Lab, Outpatient Medical, Continuing Care Retirement Community (CCRC), and Other Non-Reportable, which provide diversification and growth opportunities.</description>
    </item>
    
    <item>
      <title>TGTX</title>
      <link>https://finan.club/us/tgtx/</link>
      <pubDate>Mon, 11 Mar 2024 09:03:54 +0000</pubDate>
      
      <guid>https://finan.club/us/tgtx/</guid>
      <description>score:113
Chances: TG Therapeutics, Inc. has announced the presentation of data from the ULTIMATE I &amp;amp; II Phase 3 trials evaluating BRIUMVIÂ® in patients with relapsing forms of multiple sclerosis, indicating potential positive outcomes from the trials. The company has reported strong financial results, with BRIUMVI U.</description>
    </item>
    
    <item>
      <title>GOTU</title>
      <link>https://finan.club/us/gotu/</link>
      <pubDate>Wed, 28 Feb 2024 09:05:45 +0000</pubDate>
      
      <guid>https://finan.club/us/gotu/</guid>
      <description>score:51
Chances: Gaotu Techedu Inc. continues to demonstrate strong financial performance, with impressive unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Risks: The company operates in a highly competitive market, with potential risks from regulatory changes and shifts in consumer behavior.</description>
    </item>
    
  </channel>
</rss>
